Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Has reproduction · 62
scATD: a high-throughput and interpretable framework for single-cell cancer drug resistance prediction and biomarker identification.
PMID 40501071 · PMC12159290 · Briefings in bioinformatics · 2025 · 8 claims · 6 setups
scATD enables high-throughput single-cell drug sensitivity prediction for new patients without model parameter retraining via bidirectional Bi-AdaIN style transfer
-
Full-text index only
Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids.
PMID 18797883 · PMC2804865 · Pediatric surgery international · 2008 · 7 claims · 3 setups
18 protein spots were differentially over-expressed in neuroblastoma spheroids compared to monolayers
-
Full-text index only
ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancer.
PMID 41748546 · PMC13004963 · Cell death & disease · 2026 · 7 claims · 8 setups
A shared PI3K/AKT-regulated signaling node governs drug adaptation across all long-term resistant (lt-res) ADA and PTX models
-
Has reproduction · 63
Extensive tissue-specific expression variation and novel regulators underlying circadian behavior.
PMID 33514540 · PMC7846174 · Science advances · 2021 · 8 claims · 8 setups
>700 tissue-specific transcriptomes generated from w1118 and 141 DGRP Drosophila lines, forming a circadian gene expression atlas
-
Full-text index only
Novel integrative genomics strategies to identify genes for complex traits.
PMID 16886998 · PMC2367618 · Animal genetics · 2006 · 8 claims · 7 setups
Forward genetics is restricted to genes harboring mutations, systematically missing network genes that causally influence disease without themselves being mutated.
-
Full-text index only
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
PMID 18676830 · PMC2680495 · Cancer research · 2008 · 8 claims · 5 setups
PIK3CA mutations are more common in hormone receptor-positive and HER2-positive tumors than in basal-like breast cancers
-
Full-text index only
MetaScreener: a robust dual-mode framework for directional prioritization of actionable signatures through multi-dataset and multi-approach integration.
PMID 41845481 · PMC13107662 · Journal of translational medicine · 2026 · 8 claims · 7 setups
MetaScreener is a dual-mode framework (DiffMetaScreener for discrete labels, CorMetaScreener for continuous variables) integrating over 4,000 analysis pipelines to compute activation/inhibition directionality indices (ADI/IDI/DI) for gene signatures
-
Full-text index only
EPInformer: scalable and integrative prediction of gene expression from promoter-enhancer sequences with multimodal epigenomic profiles.
PMID 41832145 · PMC13133354 · Nature communications · 2026 · 8 claims · 7 setups
EPInformer outperforms existing gene expression prediction models (Xpresso, CREaTor, Seq-GraphReg, Enformer, Borzoi) in rigorous 12-fold cross-chromosome validation for both RNA-seq and CAGE expression prediction
-
Full-text index only
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.
PMID 42020604 · PMC13175895 · Nature genetics · 2026 · 8 claims · 6 setups
A generalizable, network-based framework was established to systematically identify combination therapies targeting complementary coexisting tumor cell states
-
Has reproduction · 68
Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients.
PMID 35012625 · PMC8743438 · Genome biology · 2022 · 8 claims · 9 setups
GENEVA (Gene Expression Variance Analysis) is a semi-automated framework that mines large-scale public RNA-seq datasets to identify conditions associated with a gene's expression variance
-
Has reproduction · 88
AuPairWise: A Method to Estimate RNA-Seq Replicability through Co-expression.
PMID 27082953 · PMC4833304 · PLoS computational biology · 2016 · 7 claims · 6 setups
Sample-sample correlation of transcript abundances is a misleading measure of replicability for assessing differential expression, because it is dominated by gene-specific dynamic ranges rather than condition-dependent variation.
-
Full-text index only
CCL3+ Neutrophil Signature Predicts Response to Neoadjuvant Toripalimab plus Chemotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Phase II Trial.
PMID 41817286 · PMC13223550 · Clinical cancer research : an official journal of the American Association for Cancer Research · 2026 · 7 claims · 8 setups
A proinflammatory, CCL3-high neutrophil subset (Neu_CCL3) is significantly enriched in the pretreatment tumor microenvironment of patients who respond to nCIT.
-
Full-text index only
Systematic background selection with BasCoD enhances contrastive dimension reduction in single cell genomics.
PMID 41844632 · PMC13144610 · Nature communications · 2026 · 8 claims · 7 setups
BasCoD is a statistical testing framework using spectral subspace inclusion theory to evaluate whether a candidate background dataset is suitable for contrastive dimension reduction of a target dataset
-
Full-text index only
Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer.
PMID 41933924 · PMC13205605 · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026 · 7 claims · 8 setups
Ferroptosis inhibition, marked by upregulation of suppressors (e.g., FTH1, GPX4) and downregulation of drivers, underlies the evolution of JQ1 resistance in TNBC cells
-
Full-text index only
Engineering NK and T cells with metabolite-sensing receptors to target solid tumors.
PMID 41872506 · PMC13132725 · Nature immunology · 2026 · 8 claims · 8 setups
GPR183, GPR84, GPR34 and GPR18 were identified as top enhancers of NK cell tumor infiltration and chemotaxis to breast and ovarian cancer via CRISPRa screens